HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:

FDA and EC Agree To Collaborate On Validation Of Animal Testing Alternatives

This article was originally published in The Rose Sheet

  • News

Executive Summary

FDA and the European Commission have struck an agreement to work together more closely in peer reviewing validation studies of alternative methods to animal tests for cosmetics, according to the European Cosmetic Toiletry and Perfumery Association (Colipa)

You may also be interested in...



Major U.S. Cosmetic Firms Say They Are Ready For Animal Test Ban In EU

The EU's upcoming ban on products tested on animals could affect the availability of some novel cosmetic ingredients, though it is unlikely to have a jarring impact on large U.S. personal-care marketers

Major U.S. Cosmetic Firms Say They Are Ready For Animal Test Ban In EU

The EU's upcoming ban on products tested on animals could affect the availability of some novel cosmetic ingredients, though it is unlikely to have a jarring impact on large U.S. personal-care marketers

“Biochips” Screen For Toxicity Without Use Of Animals

Emerging "biochip" technology that assesses the toxicity of chemicals to humans in vitro could be of use to personal-care firms faced with an approaching ban on animal testing in Europe
Table

View full table

Related Content

HBW Insight HBW Insight HBW Insight HBW Insight
Tags:
UsernamePublicRestriction

Register

RS015080

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By